Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.83)
# 3,180
Out of 5,182 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $14.95 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $35.09 | +95.92% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $2.75 | +154.55% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $1.00 | +1,400.00% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $1,080 | $5.95 | +18,051.26% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $84.39 | -58.53% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $18.02 | +177.47% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $2,470 → $1,520 | $2.89 | +52,495.16% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $8.12 | +1,193.10% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $48.60 | -40.33% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $5.66 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $14.95
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $35.09
Upside: +95.92%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $2.75
Upside: +154.55%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.00
Upside: +1,400.00%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $1,080
Current: $5.95
Upside: +18,051.26%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $84.39
Upside: -58.53%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $18.02
Upside: +177.47%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $2,470 → $1,520
Current: $2.89
Upside: +52,495.16%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $8.12
Upside: +1,193.10%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $48.60
Upside: -40.33%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $5.66
Upside: -